Volume 11, Issue 4 (Nov 2023)
Res Mol Med (RMM) 2023, 11(4): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rezaei M, Sabzali S, Satari M, Parhamfar M. Immunoinformatics Vaccine targeting S1-NTD and HA2 to against SARS-CoV-2 and Influenza. Res Mol Med (RMM) 2023; 11 (4)
URL: http://rmm.mazums.ac.ir/article-1-538-en.html
URL: http://rmm.mazums.ac.ir/article-1-538-en.html
1- Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Islamic Republic of Iran , m.rezaeibio@gmail.com
2- Department of Biology, Faculty of Science, Lorestan University, Khorramabad, Islamic Republic of IRAN
3- Department of Biophysics, Malayer University, Malayer, Iran
4- Department of microbiology, Arak university of medical science, Arak, Islamic Republic of IRAN
2- Department of Biology, Faculty of Science, Lorestan University, Khorramabad, Islamic Republic of IRAN
3- Department of Biophysics, Malayer University, Malayer, Iran
4- Department of microbiology, Arak university of medical science, Arak, Islamic Republic of IRAN
Abstract: (348 Views)
This article has no abstract.
Keywords: Bivalent vaccine, Fusion peptide, HA 2 protein, Influenza A (H1N1), SARS-COV2, spike glycoprotein S1.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
